SARS-CoV-2 ORF7a antibody (AA 16-111)
Quick Overview for SARS-CoV-2 ORF7a antibody (AA 16-111) (ABIN7469591)
Target
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 16-111
-
Cross-Reactivity
- SARS Coronavirus (SARS-CoV), SARS Coronavirus-2 (SARS-CoV-2)
-
Purification
- Affinity purified by Protein G.
-
Immunogen
- The immunogen used to generate this antibody corresponds to SARS-CoV ORF7a protein (16-111 a.a.).
-
Isotype
- IgG1
-
-
-
-
Application Notes
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Comment
-
Positive Control: ORF7a-transfected 293T cell
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, No Preservative
-
Preservative
- Without preservative
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- SARS-CoV-2 ORF7a
-
Background
- 2019-nCoV ORF7a , SARS-coV-2 ORF7a , COVID-19 ORF7a
Target
-